Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Human Follicular Dendritic Cells Remain Uninfected and Capture Human Immunodeficiency Virus Type 1 through CD54-CD11a Interaction

Masatoshi Fujiwara, Rikiya Tsunoda, Shiro Shigeta, Tomoyuki Yokota, Masanori Baba
Masatoshi Fujiwara
Rational Drug Design Laboratories, Fukushima 960-1242,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rikiya Tsunoda
Department of Anatomy and Histology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiro Shigeta
Department of Microbiology, School of Medicine, Fukushima Medical University, Fukushima 960-1247, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoyuki Yokota
Rational Drug Design Laboratories, Fukushima 960-1242,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Baba
Division of Human Retroviruses, Center for Chronic Viral Diseases, Faculty of Medicine, Kagoshima University, Kagoshima 890-8520, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.73.5.3603-3607.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

It has been reported that human immunodeficiency virus type 1 (HIV-1) bound to follicular dendritic cells (FDCs) remains highly infectious to CD4+ T cells even when it forms immune complexes with neutralizing antibody (HIV-1/IC). To elucidate the role of FDCs in HIV-1 transmission to CD4+ T cells in lymph nodes, we have isolated and purified FDCs from human tonsils and examined whether the HIV-1/IC trapped on their surface is infectious to CD4+ T cells. To our surprise, not the HIV-1/IC but the antibody-free HIV-1 on FDCs could be transmitted to CD4+ T cells. Furthermore, in contrast to previous studies showing that FDCs are productively infected with HIV-1, the present study clearly demonstrated that FDCs were not the target cells for HIV-1 infection. FDCs could capture the viral particles on their surface; however, the binding of HIV-1 to FDCs was strongly inhibited by the presence of anti-CD54 (ICAM-1) monoclonal antibody (MAb) and anti-CD11a (LFA-1) MAb, suggesting that the adhesion molecules play an important role in the interaction between HIV-1 and FDCs.

The germinal centers play a key role in producing memory B cells and plasma cells. The main constituents of germinal center microenvironment are activated germinal-center B cells (centroblasts and centrocytes), follicular dendritic cells (FDCs), macrophages, CD4+ and CD8+ T cells, and dendritic cells (6, 10, 12, 13, 16, 17, 26). FDCs belong to so-called B-cell-associated dendritic cells with desmosomal junctions (29), and they have two notable characteristics. First, FDCs have very intimate relationships with the germinal-center B cells such as thymic nurse cells in vitro and in vivo (13, 15, 34, 36). Second, they are long-term antigen-presenting cells for the germinal-center B cells (18, 19, 28). The latter function seems important in pathological conditions such as with infectious diseases.

In human immunodeficiency virus type 1 (HIV-1) infection, FDCs not only handle the viral antigens but also interact with infectious virions. This is particularly relevant to the pathogenesis of this disease, since the CD4+ T cells that migrated into the light zone of the germinal centers can be infected with HIV-1 trapped on the surface of the FDCs. The first evidence that the germinal centers were infected with HIV-1 was provided by ultrastructural analysis for lymph nodes obtained from infected patients (1). The virions were located in the interdendritic extracellular spaces and embedded in a moderately electron-dense material covering the surface of the FDCs. This localization indicated that the capture of HIV-1 with immunoglobulins by FDCs was responsible for the infection of the germinal centers. Stahmer et al. reported that normal human tonsil FDCs were highly susceptible to HIV-1 infection in a CD4-independent fashion in vitro (25). Furthermore, the HIV-1-infected FDCs not only contain proviral DNA but also produce viral particles and transmit them to CD4+ T cells (24). When HIV-1 formed immune complexes with its neutralizing antibody (HIV-1/IC) and was trapped by FDCs, the virus remained highly infectious to CD4+ T cells (11). However, our previous study demonstrated that FDCs themselves were not susceptible to HIV-1 infection (33). We also found that more HIV-1 particles were trapped by fresh FDCs than by dedifferentiated FDCs or control fibroblasts, yet the surface molecules mediating this binding could not be determined. In the present study, we have isolated and purified FDCs from human tonsils and examined the infectivity of HIV-1 particles trapped on their surface. We have shown that not the HIV-1/IC but the antibody-free HIV-1 on FDCs can be transmitted to CD4+ T cells. Furthermore, the adhesion molecules CD54 (ICAM-1) and CD11a (LFA-1) play an important role in the interaction between HIV-1 particles and FDCs.

MATERIALS AND METHODS

Isolation and cultivation of FDCs.FDCs were isolated and purified from surgically resected fresh palatine tonsils, which were kindly provided by M. Hattori (Fujita General Hospital, Fukushima, Japan). The methods for enucleation and subsequent digestion of lymph follicles have been previously described (31-33). Briefly, more than 200 lymph follicles were enucleated from ca. 1-mm-thick slices of tonsil under an anatomical microscope. The follicles were then digested with an enzyme cocktail of collagenase A (0.5 mg/ml; Boehringer Mannheim, Mannheim, Germany), dispase II (0.5 mg/ml; Boehringer Mannheim) and DNase I (0.04 mg/ml; Boehringer Mannheim). FDC clusters (FDCs engulfing several germinal-center lymphocytes) (14) were then separated from the free cell suspension by four repeated sedimentations. After final purification, the ratio of FDC clusters to mixed free cells was approximately 97% (vol/vol). To remove contaminating macrophages, the FDC cluster-enriched fraction was cultured in plastic culture dishes with RPMI 1640 supplemented with 10% fetal calf serum (BioWhittaker, Walkersville, Md.) at 37°C for 60 min. The nonadherent population was transferred to other plastic culture dishes (Corning Glass Works, Corning, N.Y.) and maintained under the same conditions. After a 6-h incubation, the plastic wells were washed with culture medium, and weakly adherent cells (FDC clusters) were collected with a cell scraper. To eliminate possible contamination with CD4+ T cells, the final FDC clusters were further purified by negative selection with CD4 antibody-labeled magnetic beads (Dynabeads M-450; Dynal A.S., Oslo, Norway).

Purification and stimulation of human CD4+ T cells.Autologous tonsillar lymphocytes were separated with Lymphprep (Nyomed Pharma, Oslo, Norway) from fresh tonsillar cells. The CD4+ T-cell population was further purified by positive selection with the above-mentioned CD4 antibody-labeled magnetic beads and detached antibody. CD4+ T cells were activated by the incubation with 100 pg of staphylococcal enterotoxin E (Toxin Technology, Sarasota, Fla.) per ml.

HIV-1 exposure of FDCs and coculture with CD4+ T cells.HIV-1/IC were prepared by incubating 5,000 50% cell culture infective doses per 100 μl of HIV-1 (IIIB strain) at 37°C for 2 h with 100 μl of fresh serum obtained from HIV-1-infected patients. FDCs were exposed to either HIV-1/IC or free HIV-1 for 12 h at 4°C. The cells were then extensively washed to remove untrapped virions and cocultured with CD4+ T cells in fresh culture medium. After a 5-day incubation at 37°C, DNA was isolated from the cells and stored at −20°C until use. The p24 antigen levels in culture supernatants were measured by a p24 antigen capture enzyme-linked immunosorbent assay (ELISA) kit (Cellular Products, Inc., Buffalo, N.Y.), according to the manufacturer’s instructions. In some experiments, the HIV-1-exposed FDCs were cocultured with activated CD4+ T cells by using a cell culture insert (0.4-μm diameter; Becton Dickinson, Franklin Lakes, N.J.) to avoid cell-to-cell contact between FDCs and CD4+ T cells. In the experiments with anti-adhesion molecule monoclonal antibodies (MAbs), FDCs were exposed to HIV-1 together with 10 μg of anti-CD54, anti-CD11a, or anti-CD106 MAb per ml at 4°C for 12 h, extensively washed, and incubated at 37°C for 5 days. The antibodies were purchased from Becton Dickinson. The cells were cocultured with activated CD4+ T cells in fresh culture medium for 4 days, and the p24 antigen production and the proviral DNA synthesis were determined.

Detection of HIV-1 proviral DNA.DNA was isolated from the cells (106 cells) with a nucleic acid extraction kit (IsoQuick; Orch Research, Bothell, Wash.). PCR analysis for HIV-1gag and β-globin DNA was performed with the primer pairs SK38/39 (20) and GH20/PC04 (3), respectively. The PCR products were analyzed by electrophoresis (1.5% agarose), stained with ethidium bromide for detection of β-globin DNA, and transferred to Hybond-N+ membranes (Amersham, Buckinghamshire, United Kingdom) for detection of HIV-1 gag DNA. The blot was hybridized with the 32P-labeled oligonucleotide probe SK-19 (20). OM-10.1 cells (7), a chronically infected clone harboring a single HIV-1 provirus, were used as a positive control.

TEM analysis.FDCs were exposed to HIV-1/IC or HIV-1 at 4°C for 12 h in the absence or presence of anti-CD54 and anti-CD11a MAbs. For transmission electron microscopy (TEM) analysis, the FDCs were treated in a routine manner, including fixation in ice-cold 2.5% glutaraldehyde buffered with 0.1 M phosphate solution (pH 7.4) for 2 h, postfixation in 1% osmium tetroxides for 1 h, dehydration, embedding in Epon, ultrathin sectioning, counterstaining, and observation by TEM (Jeol, Tokyo, Japan).

RESULTS

FDCs are not the target cells for HIV-1 but transmit the virus to CD4+ T cells.Heath et al. reported that FDCs could convert the neutralized HIV-1 into an infectious form even in the presence of a vast excess of neutralizing antibody (11). Therefore, we first examined whether CD4+ T cells could be infected with HIV-1/IC, which might be trapped by FDCs. Establishment of infection was monitored by p24 antigen production in culture supernatants and by proviral DNA synthesis in the cells. When purified FDCs were exposed to HIV-1/IC for 12 h at 4°C, extensively washed, and cocultured with activated CD4+ T cells for 5 days at 37°C, the levels of p24 antigen in the culture supernatants were 0.16 and 0.10 ng/ml in experiments 1 and 2, respectively (Table1). These values were only four- to fivefold higher than those in the FDC culture without CD4+T cells (0.04 and 0.02 ng/ml, respectively).

View this table:
  • View inline
  • View popup
Table 1.

Infectivity and replication of HIV-1 trapped on the surface of FDCs

The patient sera used in this assay seemed to efficiently neutralize the infectivity of HIV-1 because a high level of HIV-1 production (>1 ng/ml) was not observed in CD4+ T cells simply exposed to HIV-1/IC without FDCs (Table 1). In order to confirm their neutralizing activity and specificity, the patients’ sera, as well as HIV-1-negative human sera, were examined for the effects on HIV-1 infectivity in MT-4 cells (a T-lymphoblastoid cell line). The patients’ sera but not the HIV-1-negative sera could reduce the viral infectivity in a dose-dependent fashion (data not shown). For instance, a patient serum achieved >3.6, 2.5, and 1.4 log10 reductions of the infectivity of the viral suspension when mixed at ratios (vol/vol) of 1:1, 1:9, and 1:99, respectively. Furthermore, HIV-1 particles could be identified on the surface of FDCs, as determined by TEM analysis (Fig. 1A). Twenty-eight viral particles were observed on the surface of 54 FDCs (51.9%). These results suggest that the reduced infectivity of HIV-1/IC is not due to the lack of HIV-1/IC capture by FDCs. Thus, we could not confirm the previous finding that FDCs converted the neutralized HIV-1 into an infectious form in the presence of neutralizing antibody (11). PCR and Southern blot analysis revealed that specific amplified products (proviral DNA) were not detectable for all samples extracted from the culture cells (Table 1), indicating that the transmission of HIV-1/IC from FDCs to CD4+ T cells does not commonly occur.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

TEM for HIV-1/IC or HIV-1-exposed FDCs. An HIV-1/IC particle (arrow in panel A) was observed on the surface of FDC (×25,000). Twenty-eight viral particles were observed on the surface of 54 FDCs (51.9%). Similarly, an antibody-free HIV-1 particle (arrow in panel B) was captured on the top of a delicate cytoplasmic process of FDCs (×10,000; inset, ×75,000). Twenty-seven particles were observed on the surface of 55 FDCs (49.1%). Pleural virions (arrows in panel C) were often observed among the extracellular spaces of fine cytoplasmic processes of FDCs in isolated FDC-lymphocytes complex (FDC cluster) (×8,000). In contrast, such virions were scarcely identified on the surfaces of FDCs treated with a combination of anti-CD54 MAb and anti-CD11a MAb (panel D). Only one particle was identified on the 64 FDCs (1.6%). Desmosomal junctions, which are a reliable morphological marker of FDCs, were observed in panels B and D (arrowheads). These pictures are representative electron micrographs of some FDCs analyzed in this study.

We next examined the same experiments with antibody-free virions. In contrast to the experiments with HIV-1/IC, the free HIV-1 retained a high degree of infectivity and, except for experiment 1, infection of the CD4+ T cells with the virus brought about a high level of p24 antigen production (6.0 and 12.5 ng/ml in experiments 2 and 3, respectively) (Table 1). When FDCs were exposed to the free virus and extensively washed, the trapped HIV-1 was found to be highly infectious. After cocultivation with CD4+ T cells, the p24 levels in the culture supernatants ranged between 6.0 ng/ml (experiment 1) and 26.0 ng/ml (experiment 2). However, it is unlikely that FDCs produced such amounts of viral antigens, and almost all of the viral particles and antigens were considered to be produced by CD4+ T cells after viral transmission from FDCs because the p24 antigen levels in the culture supernatant of FDCs alone were extremely low (undetectable levels to 0.07 ng/ml). Furthermore, the PCR analysis showed that the proviral DNA was undetectable for the samples extracted from the FDCs alone after viral exposure (Table 1), confirming that FDCs themselves are not the target cells for HIV-1 replication. In addition, it is also clear that the virions trapped on the surface of FDCs (Fig. 1B and C) were highly transmissible to the susceptible cells.

Cell-to-cell contact is necessary for HIV-1 transmission from FDCs to CD4+ T cells.To examine whether the transmission of HIV-1 from FDCs to CD4+ T cells requires cell-to-cell contact, HIV-1-exposed FDCs were separated from CD4+ T cells in the same wells by using a filter with a 0.4-μm diameter (cell culture insert). Again, high levels of p24 antigen production were observed in two separate experiments when HIV-1-exposed FDCs and CD4+ T cells were in contact with each other (Table2). In contrast, much less amounts (undetectable levels and 0.7 ng/ml) of the antigens were produced in the culture supernatants when HIV-1-exposed FDCs and CD4+ T cells were incubated without this contact. In these experiments, proviral DNA was detected for the cocultured cells but not for the cells separately cultured (Table 2). These results indicate that cell-to-cell contact is required for HIV-1 transmission from FDCs to CD4+ T cells.

View this table:
  • View inline
  • View popup
Table 2.

Infectivity and replication of HIV-1 trapped on the surface of FDCs under different culture conditions

Adhesion molecules play a crucial role in HIV-1 binding to FDCs.Although it is clear that FDCs capture HIV-1 on their surface, the molecular mechanism of their interaction is not yet fully understood. Therefore, we examined the influence of various anti-adhesion molecule MAbs on the HIV-1 capture activity of FDCs. To this end, FDCs were isolated and purified from the tonsils of several donors and exposed to HIV-1 in the absence or presence of the MAbs. After a 12-h incubation at 4°C, the cells were extensively washed to remove untrapped virions and cultured at 37°C for 5 days. Then the cells were cocultured with CD4+ T cells. As shown in Fig.2, the treatment with anti-CD54 MAb or the combination of anti-CD54 MAb with anti-CD11a MAb significantly reduced the production of p24 antigens from cocultured CD4+T cells. However, the treatment with anti-CD106 (VCAM-1) MAb did not affect the p24 antigen production. These results suggest that anti-CD54 and anti-CD11a MAbs either block the entrapment of virions on the surface of FDCs or interfere with the transmission of trapped virions to cocultured CD4+ T cells. To distinguish between these two possibilities, HIV-1-exposed FDCs in the absence or presence of the MAbs were analyzed by TEM. HIV-1 particles were observed on the surface of FDCs frequently (49.1% of total FDCs observed) when the cells were not treated with the anti-CD54 and anti-CD11a MAbs (Fig. 1B and C). In contrast, such particles were hardly (1.6%) identified on the surface of FDCs that had been treated with the MAbs (Fig. 1D).

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Inhibitory effects of anti-adhesion molecule MAbs on the entrapment and infectivity of HIV-1 in FDC cultures. FDCs were isolated and purified from human tonsils and exposed to HIV-1 at 4°C for 12 h in the absence (a) or in the presence of anti-CD54 (ICAM-1) MAb (b), anti-CD11a (LFA-1) MAb (c), anti-CD54 MAb plus anti-CD11a MAb (d), or anti-CD106 (VCAM-1) MAb (e). The cells were extensively washed and incubated at 37°C. After a 5-day incubation, FDCs were cocultured with activated CD4+ T cells in fresh culture medium for 4 days. The p24 antigen levels were determined by antigen capture ELISA and expressed as a percentage of the control culture (a). The mean values in each group are indicated by horizontal bars, and the statistical significance was analyzed by the t test.

DISCUSSION

Initial studies on HIV-1 pathogenesis in lymph nodes have revealed a novel and surprising finding that FDCs are responsible for the infection of germinal centers. FDCs are peculiar dendritic cells that carry immune complexes on their surfaces (18, 35). Health et al. reported that, once HIV-1 was trapped by FDCs, the virus became highly infectious to CD4+ T cells even in the presence of antibodies that would otherwise neutralize it (11). However, we demonstrated that FDCs could not transmit HIV-1/IC to CD4+ T cells, though FDCs could capture HIV-1/IC on their surface (Table 1 and Fig. 1A). The reason for this discrepancy may be due to the differences in neutralizing antibodies used in our experiments. We speculate that, in the earlier experiments, the formation of HIV-1/IC might have been incomplete and therefore the antibody-free particles were also trapped on the surface of FDCs together with HIV-1/IC. In our study, we repeated the experiment with FDCs from different donors and with sera from different patients, yet a reproducible result was obtained (Table 1). Furthermore, HIV-1/IC was found to be much less infectious to CD4+ T cells than was the free HIV-1 and, even when trapped, FDCs could not convert the virus into its infectious form.

Another important finding in this study is that FDCs themselves were not susceptible to HIV-1 infection, irrespective of the viral forms (immune complex or free) and did not produce the viral antigens during at least a 5-day culture period (Table 1). Previous studies in immunohistochemistry and electron microscopy demonstrated that FDCs play an important role in the pathogenesis of AIDS, serving as a major reservoir of HIV-1 (1, 23, 27). Our electron microscopic observations also indicated that the trapped virions were morphologically intact. Thus, FDCs appear to be sequentially supplied with infectious virions and to function as a viral reservoir, where the virus remains infectious to CD4+ T cells for several days.

Although the molecular mechanism involved in the entrapment of HIV-1 by FDCs is of particular importance, it has not been elucidated yet. Blauvelt et al. reported that the productive infection of T-cell-associated dendritic cells with HIV-1 and their ability to capture the virus were mediated through separate machineries. The former was dependent on the CD4 molecule and HIV-1 coreceptors, while the latter was not (4). FDCs do not express CD4 and the coreceptors on their surface (5, 22, 37), suggesting that FDCs use other mechanisms for the capture HIV-1 particles. We previously reported that the infectivity of FDC-trapped HIV-1 was lost during a 25-day incubation period (33). The expression of adhesion and costimulatory molecules on FDCs were rapidly downregulated in vitro, and the amount of expressed CD54 after a 35-day incubation was less than one-hundredth of that after a 7-day incubation (32). Furthermore, the interaction between the virus-incorporated and the host cellular adhesion molecules CD54 and CD11a is known to markedly enhance the capacity of HIV-1 for its binding and entry into CD4+ T cells (2, 8, 9, 21, 30). These findings and our present observations strongly suggest the use of CD54 and CD11a in the FDC capture of HIV-1 particles.

In conclusion, we have demonstrated that (i) FDCs are able to capture HIV-1 on their surfaces in vitro, (ii) that the FDC-trapped virions remain infectious and are transmitted to cocultured CD4+ T cells but (iii) that the FDCs themselves are not susceptible to these virions, and (iv) that the adhesion molecules expressed on FDCs and the viral envelope play an important role in the interaction between FDCs and HIV-1. Further studies are required to elucidate the complete functions of the FDCs in the pathogenesis of HIV-1 infection.

ACKNOWLEDGMENTS

M.F. and R.T. contributed equally to this work.

OM-10.1 cells were obtained through the AIDS Research and Reference Reagent Program, National Institute of Allergy and Infectious Diseases, Bethesda, Md. (the contributor was S. Butera).

FOOTNOTES

    • Received 19 August 1998.
    • Accepted 13 January 1999.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Armstrong J. A.,
    2. Horne R.
    Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy.Lancet ii 1984 370 372
    OpenUrl
  2. 2.↵
    1. Bastiani L.,
    2. Laal S.,
    3. Kim M.,
    4. Zolla-Pazner S.
    Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions.J. Virol. 71 1997 3444 3450
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bauer H. M.,
    2. Ting Y.,
    3. Greer C. E.,
    4. Chambers J. C.,
    5. Tashiro C. J.,
    6. Chimera J.,
    7. Reingold A.,
    8. Manos M. M.
    Genital human papillomavirus infection in female university students as determined by a PCR-based method.JAMA 265 1991 472 477
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Blauvelt A.,
    2. Asada H.,
    3. Saville N. W.,
    4. Klaus-Kovtun V.,
    5. Altman D. J.,
    6. Yarchoan R.,
    7. Katz S. I.
    Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.J. Clin. Invest. 100 1997 2043 2053
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Butch A. W.,
    2. Chung G.-H.,
    3. Hoffmann J. W.,
    4. Nahm M. H.
    Cytokine expression by germinal center cells.J. Immunol. 150 1993 39 47
    OpenUrlAbstract
  6. 6.↵
    1. Butcher E. C.,
    2. Rouse R. V.,
    3. Coffman R. L.,
    4. Nottenburg C. N.,
    5. Hardy R. R.,
    6. Weissman I. L.
    Surface phenotype of Peyer’s patch germinal center cells: implications for the role of germinal centers in B cell differentiation.J. Immunol. 129 1982 2698 2707
    OpenUrlAbstract
  7. 7.↵
    1. Butera S. T.,
    2. Perez P. L.,
    3. Wu B.-Y.,
    4. Nabel G. J.,
    5. Folks T. M.
    Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.J. Virol. 65 1991 4645 4653
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Fortin J.-F.,
    2. Cantin R.,
    3. Lamontagne G.,
    4. Tremblay M. J.
    Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity.J. Virol. 71 1997 3588 3596
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Fortin J.-F.,
    2. Cantin R.,
    3. Tremblay M. J.
    T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.J. Virol. 72 1998 2105 2112
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Grouard G.,
    2. Durand I.,
    3. Filgueira L.,
    4. Banchereau J.,
    5. Liu Y. J.
    Dendritic cells capable of stimulating T cells in germinal centres.Nature 384 1996 364 367
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Heath S. L.,
    2. Tew J. G.,
    3. Szakal A. K.,
    4. Burton G. F.
    Follicular dendritic cells and human immunodeficiency virus infectivity.Nature 377 1995 740 744
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Heinen E.,
    2. Cormann N.,
    3. Kinet-Denoël C.
    The lymph follicle: a hard nut to crack.Immunol. Today 9 1988 240 243
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Imai Y.,
    2. Yamakawa M.
    Morphology, function and pathology of follicular dendritic cells.Pathol. Int. 46 1996 807 833
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Lilet-Leclercq C.,
    2. Radoux D.,
    3. Heinen E.,
    4. Kinet-Denoel C.,
    5. Defraigne J. O.,
    6. Houben-Defresne M. P.,
    7. Simar L. J.
    Isolation of follicular dendritic cells from human tonsils and adenoids. I. Procedure and morphological characterization.J. Immunol. Methods 66 1984 235 244
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Lindhout E.,
    2. Lakeman A.,
    3. de Groot C.
    Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease.J. Exp. Med. 181 1995 1985 1995
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Liu Y. J.,
    2. Johnson G. D.,
    3. Gordon J.,
    4. MacLennan I. C.
    Germinal centers in T-cell-dependent antibody responses.Immunol. Today 13 1992 17 21
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. MacLennan I. C.,
    2. Gray D.
    Antigen-driven selection of virgin and memory B cells.Immunol. Rev. 91 1986 61 85
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Nossal G. J. V.
    Differentiation of the secondary B-lymphocyte repertoire: The germinal center reaction.Immunol. Rev. 137 1994 173 183
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Nossal G. J. V.,
    2. Abbott A.,
    3. Mitchell J.,
    4. Lummus Z.
    Antigens in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles.J. Exp. Med. 127 1968 277 290
    OpenUrlAbstract
  20. 20.↵
    1. Ou C.-Y.,
    2. Kwok S.,
    3. Mitchell S. W.,
    4. Mack D. H.,
    5. Sninsky J. J.,
    6. Krebs J. W.,
    7. Feorino P.,
    8. Warfield D.,
    9. Schochetman G.
    DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.Science 239 1988 295 297
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Rizzuto C. D.,
    2. Sodroski J. G.
    Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization.J. Virol. 71 1997 4847 4851
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Schriever F.,
    2. Freedman A. S.,
    3. Freeman G.,
    4. Messner E.,
    5. Lee G.,
    6. Daley J.,
    7. Nadler L. M.
    Isolated human follicular dendritic cells display a unique antigenic phenotype.J. Exp. Med. 169 1989 2043 2058
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Spiegel H.,
    2. Herbst H.,
    3. Niedobitek G.,
    4. Foss H.-D.,
    5. Stein H.
    Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.Am. J. Pathol. 140 1992 15 22
    OpenUrlPubMedWeb of Science
  24. 24.↵
    1. Sprenger R.,
    2. Toellner K.-M.,
    3. Schmetz C.,
    4. Lüke W.,
    5. Stahl-Henning C.,
    6. Ernst M.,
    7. Hunsmann G.,
    8. Schmitz H.,
    9. Flad H.-D.,
    10. Gerdes J.,
    11. Zimmer J. P.
    Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cells.Med. Microbiol. Immunol. 184 1995 129 134
    OpenUrlPubMed
  25. 25.↵
    1. Stahmer I.,
    2. Zimmer J. P.,
    3. Ernst M.,
    4. Fenner T.,
    5. Finnern R.,
    6. Schmitz H.,
    7. Flad H.-D.,
    8. Gerdes J.
    Isolation of normal human follicular dendritic cells and CD4-independent in vitro infection by human immunodeficiency virus (HIV-1).Eur. J. Immunol. 21 1991 1873 1878
    OpenUrlPubMed
  26. 26.↵
    1. Stein H.,
    2. Gerdes J.,
    3. Mason D. Y.
    The normal and malignant germinal centre.Clin. Haematol. 11 1982 531 559
    OpenUrlPubMedWeb of Science
  27. 27.↵
    1. Tenner-Rácz K.,
    2. Rácz P.,
    3. Dietrich M.,
    4. Kern P.
    Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy.Lancet i 1985 105 106
    OpenUrl
  28. 28.↵
    1. Tew J. G.,
    2. Mandel T. E.,
    3. Burgess A. W.
    Retention of intact HSA for prolonged periods in the popliteal lymph nodes of specifically immunized mice.Cell. Immunol. 45 1979 207 212
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Tew J. G.,
    2. Thorbecke G. J.,
    3. Steinman R. M.
    Dendritic cells in the immune response: characteristic and recommended nomenclature (a report from the Reticuloendothelial Society Committee on nomenclature).J. Reticuloendothel. Soc. 31 1982 371 380
    OpenUrlPubMedWeb of Science
  30. 30.↵
    1. Tremblay M. J.,
    2. Fortin J. F.,
    3. Cantin R.
    The acquisition of host-encoded proteins by nascent HIV-1.Immunol. Today 19 1998 346 351
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Tsunoda R.
    Long-term cultivation of human follicular dendritic cells Follicular dendritic cells in normal and pathological conditions. R. G. Heinen E. 1995 111 124 Landes Co. Austin, Tex
  32. 32.↵
    1. Tsunoda R.,
    2. Bosseloir A.,
    3. Onozaki K.,
    4. Heinen E.,
    5. Miyake K.,
    6. Okamura H.,
    7. Suzuki K.,
    8. Fujita T.,
    9. Simar L. J.,
    10. Sugai N.
    Human follicular dendritic cells in vitro and follicular dendritic-cell-like cells.Cell Tissue Res. 288 1997 381 389
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Tsunoda R.,
    2. Hashimoto K.,
    3. Baba M.,
    4. Shigeta S.,
    5. Sugai N.
    Follicular dendritic cells in vitro are not susceptible to infection by HIV-1.AIDS 10 1996 595 602
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Tsunoda R.,
    2. Nakayama M.,
    3. Heinen E.,
    4. Miyake K.,
    5. Suzuki K.,
    6. Sugai N.,
    7. Kojima M.
    Emperipolesis of lymphoid cells by human follicular dendritic cells in vitro.Virchows Arch. B Cell Pathol. 62 1992 69 78
    OpenUrlPubMed
  35. 35.↵
    1. Van Rooijen N.
    The role of the FDC-retained immune complex network and its dynamics in the activity of germinal centres.Res. Immunol. 144 1993 545 552
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Wekerle H.,
    2. Ketelsen U.-P.
    Thymic nurse cells. Ia-bearing epithelium involved in T-lymphocyte differentiation? Nature 283 1980 402 404
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Zhang L.,
    2. He T.,
    3. Talal A.,
    4. Wang G.,
    5. Frankel S. S.,
    6. Ho D. D.
    In vitro distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5.J. Virol. 72 1998 5035 5045
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Human Follicular Dendritic Cells Remain Uninfected and Capture Human Immunodeficiency Virus Type 1 through CD54-CD11a Interaction
Masatoshi Fujiwara, Rikiya Tsunoda, Shiro Shigeta, Tomoyuki Yokota, Masanori Baba
Journal of Virology May 1999, 73 (5) 3603-3607; DOI: 10.1128/JVI.73.5.3603-3607.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human Follicular Dendritic Cells Remain Uninfected and Capture Human Immunodeficiency Virus Type 1 through CD54-CD11a Interaction
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Human Follicular Dendritic Cells Remain Uninfected and Capture Human Immunodeficiency Virus Type 1 through CD54-CD11a Interaction
Masatoshi Fujiwara, Rikiya Tsunoda, Shiro Shigeta, Tomoyuki Yokota, Masanori Baba
Journal of Virology May 1999, 73 (5) 3603-3607; DOI: 10.1128/JVI.73.5.3603-3607.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

dendritic cells
HIV-1
Intercellular Adhesion Molecule-1
Lymphocyte Function-Associated Antigen-1

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514